SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Spartex who wrote (42379)5/28/1999 9:50:00 AM
From: pooh  Respond to of 120523
 
DIR - in@40-5/8 out 42-1/4



To: Spartex who wrote (42379)5/28/1999 11:10:00 AM
From: Street Walker  Read Replies (1) | Respond to of 120523
 
GUMM brokerage mtg was after the close.
It may have been a mtg of brokers that already loaded up
their customers.

Zicam was test marketed in 8,000 stores
over the last 3 months. This next cold
season, they will be in over 50,000 stores.

zicam.com



To: Spartex who wrote (42379)5/28/1999 9:51:00 PM
From: Street Walker  Read Replies (1) | Respond to of 120523
 
GUMM - Long Term Hold - zicam treatment for common cold

Message 9372766

Quad-K, the above msg gives you an idea why I like
this as a long term investment. I believe its a safe haven
with superb growth potential. Many don't know about
generic nicorette chewing gum or dental gums or the
best treatment for the common cold, but that's okay.
More investors will take notice of the growth potential
as time goes by. And once again, this is not a daytrading
stock.

Can you think of a bigger market than the common cold?
Zicam zicam.com
was just test marketed in 8,000 stores the last 3 months.
Each store reorderd an average of 5 times! Zicam will
be in 50,000+ stores this comming cold season. Profit
margin on this is extremely high. Next move is International.

Watch the trades and you'll see its being accumulated 'smartly'
by large investors.

Regards,
S.W.